Skip to Main Content

Paper Details

Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma.
Cancer Cytopathol
10
2022
Author NameAffiliation
Michelle D WilliamsThe University of Texas MD Anderson Cancer Center
Clifton D FullerThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2